The objective of this study is to evaluate arm rejuvenation and tightening with a nanofractional radiofrequency device, Venus viva, Venus concept, Toronto Canada. We recruit 20 subjects. All 20 subjects are treated with 3 sessions, 1 month interval with a nano fractional radiofrequency device on the inner upper arm. We evaluate skin tightening using %improvement of treated surface areas and skin elasticity using Dermalab the result at 3 months after the last treatment and clinical improvements evaluated by two board certified dermatologist (using compared photos between before treatment and 3 months after the last treatment).
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
TREATMENT
Masking
NONE
Enrollment
20
A nanofractional radiofrequency device. noninvasive fractional radiofrequency device that provides ability to control and adjust the ratio of ablation and coagulation effect. Venus Viva, licensed by Health Canada, is cleared by the FDA for ablation and resurfacing dermatological procedures.
Department of Dermatology, Faculty of Medicine, Chulalongkorn University
Bangkok, Bangkok, Thailand
RECRUITINGEffects of arm rejuvenation and tightening
Determined by changing of the treated surface area (calculated from four-fixed tattoo points on the inner arm) surface area = length x width cm2
Time frame: 12 weeks after the last treatment
Changing of skin laxity and elasticity
Evaluated by skin's viscoelastic properties using Dermalab, Courage Khazaka Electronic GmbH
Time frame: 12 weeks after the last treatment
Changing of skin wrinkles and laxity using photographs of subjects' baselines and 12 weeks after the last treatment by two independent board certified dermatologists
Determined by five point scale. (1) excellent improvement (\>75%), (2) good improvement (50-75%), (3) fair improvement (25-50%), (4) some improvement (10-25%) and (5) little or no improvement (0-10%)
Time frame: 12 weeks after the last treatment
evaluate perceptions of treatment with a nano-fractional radiofrequency device
using five-point scale Five point scale evaluation: (1) excellent improvement (\>75%), (2) good improvement (50-75%), (3) fair improvement (25-50%), (4) some improvement (10-25%) and (5) little or no improvement (0-10%)
Time frame: 12 weeks after the last treatment
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.